Omalizumab
Records for this ingredient, by country (identity only).
ATC R03DX05 · 13 markets · 120 records
Omalizumab
Forms
AU 27 records · 6 shown of 6
Only this ingredient
- 150 mg per mL / per unit basis not statedinjectionMOVABEY omalizumab (rch) 75 mg solution for injection pre-filled penOMLYCLO omalizumab (rch) 150 mg/ mL solution for injection in a pre-filled syringe with needle guard、OMLYCLO omalizumab (rch) 150 mg/ mL solution for injection pre-filled pen、XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled pen、XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled syringe、XOLAIR omalizumab (rch) 75mg powder for injection vial with diluent ampoule
- 75 mg/0.5 mLinjectionOMLYCLOXolair
- 150 mg/1 mLinjectionOMLYCLOXolair
- 300 mg/2 mLinjectionXolair
- 75 mg per mL / per unit basis not statedinjectionMOVABEY omalizumab (rch) 75 mg solution for injection pre-filled penOMLYCLO omalizumab (rch) 75 mg/0.5 mL solution for injection in a pre-filled syringe with needle guard、OMLYCLO omalizumab (rch) 75 mg/0.5 mL solution for injection pre-filled pen、XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled pen、XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled syringe、XOLAIR omalizumab (rch) 75mg powder for injection vial with diluent ampoule
- 300 mg per mL / per unit basis not statedinjectionMOVABEY omalizumab (rch) 75 mg solution for injection pre-filled penOMLYCLO omalizumab 300 mg/ 2 mL solution for injection pre-filled pen、OMLYCLO omalizumab 300 mg/ 2 mL solution for injection pre-filled syringe with safety guard、XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled pen、XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled syringe
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名OMLYCLO ×2Xolair ×2
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 13 records · 4 shown of 4
Only this ingredient
- 150 mg per mL / per unit basis not statedinjectionXolair 150mg powder and solvent for solution for injection vials
- 75 mg/0.5 mLinjectionOmlyclo 75mg/0.5ml solution for injection pre-filled pensOmlyclo 75mg/0.5ml solution for injection pre-filled syringes、Xolair 150mg/1ml solution for injection pre-filled pens、Xolair 75mg/0.5ml solution for injection pre-filled syringes
- 150 mg/1 mLinjectionOmlyclo 75mg/0.5ml solution for injection pre-filled pensOmlyclo 75mg/0.5ml solution for injection pre-filled syringes、Xolair 150mg/1ml solution for injection pre-filled pens、Xolair 75mg/0.5ml solution for injection pre-filled syringes
- 300 mg/2 mLinjectionOmlyclo 75mg/0.5ml solution for injection pre-filled pensOmlyclo 75mg/0.5ml solution for injection pre-filled syringes、Xolair 150mg/1ml solution for injection pre-filled pens、Xolair 75mg/0.5ml solution for injection pre-filled syringes
CA 13 records · 4 shown of 4
US 11 records · 4 shown of 4
Only this ingredient
- 150 mg per mL / per unit basis not statedinjectionOMLYCLOXolair PFS、Manufacturer: Novartis Pharma Stein AG
- 75 mg/0.5 mLinjectionOMLYCLOXolair PFS、Manufacturer: Novartis Pharma Stein AG
- 300 mg/2 mLinjectionOMLYCLOXolair、Manufacturer: Novartis Pharma Stein AG
- 150 mg/1.2 mLinjectionXolairManufacturer: Novartis Pharma Stein AG
JP 10 records · 4 shown of 4
Only this ingredient
- 150 mg per mL / per unit basis not statedinjectionゾレア皮下注用150mg
- 75 mg/0.5 mLinjectionオマリズマブBS皮下注75mgシリンジ「CT」オマリズマブBS皮下注75mgペン「CT」、ゾレア皮下注75mgシリンジ、ゾレア皮下注75mgペン
- 150 mg/1 mLinjectionオマリズマブBS皮下注150mgシリンジ「CT」オマリズマブBS皮下注150mgペン「CT」、ゾレア皮下注150mgシリンジ、ゾレア皮下注150mgペン
- 300 mg/2 mLinjectionゾレア皮下注300mgペン
FR 10 records · 3 shown of 3
Only this ingredient
- 75 mg/0.5 mLinjectionOMLYCLO 150 mg, solution injectable en seringue préremplieOMLYCLO 150 mg, solution injectable en stylo prérempli、XOLAIR 150 mg, solution injectable en seringue préremplie、XOLAIR 150 mg, solution injectable en stylo prérempli
- 150 mg/1 mLinjectionOMLYCLO 150 mg, solution injectable en seringue préremplieOMLYCLO 150 mg, solution injectable en stylo prérempli、XOLAIR 150 mg, solution injectable en seringue préremplie、XOLAIR 150 mg, solution injectable en stylo prérempli
- 300 mg/2 mLinjectionXOLAIR 300 mg, solution injectable en seringue pré-remplieXOLAIR 300 mg, solution injectable en stylo pré-rempli
HK 8 records · 0 shown of 0
8 records · 0 manufacturers 8 registros · 0 fabricantes 8 个记录 · 0 个厂家 8 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名XOLAIR FOR INJ WITH SOLVENT 150MG ×1XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/1.0ML ×3XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/ML ×1XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/ML ×2XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2.0ML ×12
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
SG 7 records · 3 shown of 3
Only this ingredient
- 75 mg/0.5 mLinjectionOMLYCLO® SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150 MG/1MLXOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2.0ML
- 150 mg/1 mLinjectionOMLYCLO® SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150 MG/1MLXOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/1.0ML、XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2.0ML
- 300 mg/2 mLinjectionXOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/1.0MLXOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2.0ML
ES 7 records · 3 shown of 3
Only this ingredient
- 150 mg per mL / per unit basis not statedinjectionOMLYCLO PRECARGADAXolair
- 75 mg per mL / per unit basis not statedinjectionOMLYCLO PRECARGADAXolair
- 300 mg per mL / per unit basis not statedinjectionOMLYCLO PRECARGADA
CN 5 records · 2 shown of 2
TW 3 records · 1 shown of 1
Only this ingredient
- 150 mg per mL / per unit basis not statedinjectionOmlyclo soluiton forXolair 150 mg powder and solvent for solution for injection、Xolair 150mg/mL Solution for Injection、休敏樂注射液劑150毫克/毫升、喜瑞樂凍晶注射劑150毫克、喜瑞樂注射液劑150毫克/毫升
EU 2 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名OMLYCLO ×2Xolair ×2
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
MX 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名OMLYCLO ×2
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | MX | TW | HK | JP | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 150 mg per mL / per unit basis not stated cannot compare injection | Manufacturer: Novartis Pharma Stein AG ×4 OMLYCLO Xolair PFS | Xolair 150mg powder and solvent for solution for injection vials | MOVABEY omalizumab (rch) 75 mg solution for injection pre-filled pen OMLYCLO omalizumab (rch) 150 mg/ mL solution for injection in a pre-filled syringe with needle guard OMLYCLO omalizumab (rch) 150 mg/ mL solution for injection pre-filled pen+3XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled pen XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled syringe XOLAIR omalizumab (rch) 75mg powder for injection vial with diluent ampoule | 恩益坦奥马珠单抗 茁乐奥马珠单抗 | OMLYCLO PRECARGADA Xolair | Omlyclo soluiton for Xolair 150 mg powder and solvent for solution for Xolair 150mg/mL Solution for | ゾレア皮下注用150mg | ||||||
| 75 mg/0.5 mL injection | Manufacturer: Novartis Pharma Stein AG ×4 OMLYCLO Xolair PFS | Omlyclo 75mg/0.5ml solution for injection pre-filled pens Omlyclo 75mg/0.5ml solution for injection pre-filled syringes Xolair 150mg/1ml solution for injection pre-filled pens | OMLYCLO Xolair | OMLYCLO® SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150 MG/1ML XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2.0ML | オマリズマブBS皮下注75mgシリンジ「CT」 オマリズマブBS皮下注75mgペン「CT」 ゾレア皮下注75mgシリンジ+1ゾレア皮下注75mgペン | OMLYCLO 150 mg, solution injectable en seringue préremplie OMLYCLO 150 mg, solution injectable en stylo prérempli XOLAIR 150 mg, solution injectable en seringue préremplie | |||||||
| 150 mg/1 mL injection | Omlyclo 75mg/0.5ml solution for injection pre-filled pens Omlyclo 75mg/0.5ml solution for injection pre-filled syringes Xolair 150mg/1ml solution for injection pre-filled pens | OMLYCLO Xolair | OMLYCLO® SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150 MG/1ML XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/1.0ML XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2.0ML | 茁乐奥马珠单抗 | オマリズマブBS皮下注150mgシリンジ「CT」 オマリズマブBS皮下注150mgペン「CT」 ゾレア皮下注150mgシリンジ+1ゾレア皮下注150mgペン | OMLYCLO 150 mg, solution injectable en seringue préremplie OMLYCLO 150 mg, solution injectable en stylo prérempli XOLAIR 150 mg, solution injectable en seringue préremplie | |||||||
| 300 mg/2 mL injection | Manufacturer: Novartis Pharma Stein AG ×4 OMLYCLO Xolair | Omlyclo 75mg/0.5ml solution for injection pre-filled pens Omlyclo 75mg/0.5ml solution for injection pre-filled syringes Xolair 150mg/1ml solution for injection pre-filled pens | Xolair | XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/1.0ML XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2.0ML | ゾレア皮下注300mgペン | XOLAIR 300 mg, solution injectable en seringue pré-remplie XOLAIR 300 mg, solution injectable en stylo pré-rempli | |||||||
| 75 mg per mL / per unit basis not stated cannot compare injection | MOVABEY omalizumab (rch) 75 mg solution for injection pre-filled pen OMLYCLO omalizumab (rch) 75 mg/0.5 mL solution for injection in a pre-filled syringe with needle guard OMLYCLO omalizumab (rch) 75 mg/0.5 mL solution for injection pre-filled pen+3XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled pen XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled syringe XOLAIR omalizumab (rch) 75mg powder for injection vial with diluent ampoule | OMLYCLO PRECARGADA Xolair | |||||||||||
| 300 mg per mL / per unit basis not stated cannot compare injection | MOVABEY omalizumab (rch) 75 mg solution for injection pre-filled pen OMLYCLO omalizumab 300 mg/ 2 mL solution for injection pre-filled pen OMLYCLO omalizumab 300 mg/ 2 mL solution for injection pre-filled syringe with safety guard+2XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled pen XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled syringe | OMLYCLO PRECARGADA | |||||||||||
| 150 mg per mL / per unit basis not stated cannot compare liquid | OMLYCLO Xolair | ||||||||||||
| 150 mg/1 mL liquid | OMLYCLO Xolair | ||||||||||||
| 75 mg per mL / per unit basis not stated cannot compare liquid | OMLYCLO Xolair | ||||||||||||
| 150 mg/1.2 mL injection | Manufacturer: Novartis Pharma Stein AG ×4 Xolair | ||||||||||||
| 150 mg powder | Xolair | ||||||||||||
unknown | OMLYCLO | XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/1.0ML XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/ML XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/ML | OMLYCLO Xolair | ||||||||||
liquid | OMLYCLO | ||||||||||||
| Combination 对-伞花烃 + Omalizumab unknown | XOLAIR FOR INJ WITH SOLVENT 150MG | ||||||||||||
| Combination Omalizumab + Polysorbate 20 unknown | Xolair |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
6 more strength/form rows are recorded only in CA · MX · HK and are not shown in this table. Hay 6 filas de concentración/forma registradas solo en CA · MX · HK que no se muestran en esta tabla. 另有 6 个规格/剂型仅在 CA · MX · HK 有记录（未在本表显示）。 另有 6 個規格/劑型僅在 CA · MX · HK 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.